Roche Abandons New Diabetes Drug
Wednesday, July 10, 2013 - 02:50
in Health & Medicine
Development of the drug, aleglitazar, was discontinued after Roche cited safety reasons and questions over its effectiveness.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via